Edinburgh01 wrote: ↑Wed Mar 24, 2021 2:41 pm
Blackrock Bullet wrote: ↑Wed Mar 24, 2021 2:30 pm
The U.K. was supposed to have 30m ready to go by the end of 2020, it had zero. 4m were brought in from Europe. A further 10m were sought from India. More went out in January and February. The U.K. are now worried about how ever million are in the Netherlands.
You seriously think I spent 24 hours researching? More like 5 minutes, just as I have now.
BTW, unattributed quotes are never a good idea.
The UK has ordered 100 million doses. Almost all will come from within the UK, but 10 million doses are being made by the Serum Institute in India.
AstraZeneca confirmed that the UK has not received any vaccines or components from the EU - apart from one "tiny" batch from the Leiden plant.
https://www.channel4.com/news/factcheck ... ine-supply
The government later confirmed that 10 million of the 100 million doses the drug company has agreed to supply would be made in India.
It came as a surprise to many people who had been following the story of vaccine manufacturing, because the understanding was that almost all vaccine for use in the UK would be made at facilities in this country, with a small amount imported from Europe.
In a briefing to journalists on December 7 last year, Ian McCubbin, manufacturing lead for the UK government’s Vaccines Taskforce, said: “The vast, vast, vast majority of what will be produced by AstraZeneca for the UK will be in the UK.”
He said a small number of doses would initially come from facilities in EU countries but added: “The remainder of the supply will be a UK supply chain.”
Yeah good man. Here are the facts;
https://www.ft.com/content/651be7e7-2a4 ... b7e887f6e8
The UK government’s vaccines task force acknowledged on Monday that just 4m doses of the vaccine developed by Oxford university and AstraZeneca would be delivered this year, imported from the Netherlands and Germany. Earlier in the year, the task force had said it envisaged production of 30m doses in the UK by year-end.
Still on course for 80% though apparently;
The “vast, vast, vast majority” - over 80% - of the 100 million doses AstraZeneca will produce for the United Kingdom will be made there, Ian McCubbin, manufacturing lead for the Vaccine Taskforce, said, but this year’s first batches will not.
The UK were due to have 30m ready to go, they had zero. The AZ CEO admitted "teething" issues in UK plants, but then claimed they were ironed out.
By February 2021, 10m of those vaccines were now going to be produced in the SII. Once again, this was not what they were originally intended to be and it was specifically cited that supply shortfalls were the reason why AZ were drafting them in. The UK went to audit that site because their supply chain was not reaching what was intended.
https://www.fiercepharma.com/manufactur ... t-covid-19
AstraZeneca set up a globetrotting supply network for its COVID-19 vaccine to deliver doses around the world, but it hasn't tapped regional producers to ease delivery shortfalls elsewhere. But that could change—and soon.
For a facility which was intended to provided doses to India and the developing world. The CEO explicitly stated that he did not believe Covax would reach targets. The reality is that these were redirected to western countries, with the UK seemingly the ones to take that up, ahead of developing countries. You either wear that or you don't, but that's reality.
The real issue issue is that the AZ CEO appeared to be lying when he stated this is January. We talk about private companies supplying private contracts but he specifically cited this;
https://www.repubblica.it/cronaca/2021/ ... 284349628/
We've had also teething issues like this in the UK supply chain. But the UK contract was signed three months before the European vaccine deal. So with the UK we have had an extra three months to fix all the glitches we experienced. As for Europe, we are three months behind in fixing those glitches.
It's clearly not credible. 80% were supposed to be from the UK. We know over 4m went outside the UK pre the year end. We know the UK was 30m short of where it needed to be. We know that the UK went and sourced 10m replacement from India. We know that more left in January and February. We know that the UK are haggling over millions more in the Netherlands right now. It's quite clear that the UK supply chain is not providing 80%. He does not want to admit that as it leaves him open.
Again, this is primarily not a UK vs. EU issue, though I accept that the EU's reaction will pull the UK into it and I disagree with that. It's primarily an AZ vs. EU issue. AZ are the same operators who have significant issues with US authorities as well i.e. a pattern of miscommunications and blunders.